Molecular Partners AG is a Switzerland-based company engaged in the pharmaceuticals industry. As a biopharmaceutical company, it is active in the research and development of proteins like DARPins (Designed Ankyrin Repeat Proteins), a new class of small proteins used for the development of medicine against diseases like cancer and sight-threating diseases, among others. The Company's pipeline is structured mainly through three areas: Ophthalmology, including the creation of therapies for renital diseases like wet age-related macular degeration (wet AMD) and diabetic macular edema (DME); Oncology, containing the development of DARPins against cancer, among others; and Immunology and other Indications, entailing DARPins against several targets important for the treatment of inflammatory and auto-immune diseases.
Company Details
- Employees
- 7
- Founded
- 2004
- Address
- Schlieren
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://molecularpartners.com
- HQ
- Schlieren
Molecular Partners Ag Questions
Molecular Partners Ag's website is http://molecularpartners.com
Molecular Partners Ag's LinkedIn profile is https://ch.linkedin.com/company/molecular-partners-ag
Molecular Partners Ag has
7 employees.
View email and phone details for 7
employees at Molecular Partners Ag.
Molecular Partners Ag's industry is
Pharmaceutical Manufacturing
Molecular Partners Ag's top competitors are
Orano Med,
Alentis Therapeutics,
Molecular Partners,
Mabylon Ag,
Memo Therapeutics Ag,
Immunos Therapeutics Ag,
Cdr-Life Inc.,
Cutiss Ag,
Numab Therapeutics Ag,
Biognosys.
Molecular Partners Ag's categories are Pharmaceutical Manufacturing
Molecular Partners Ag's founding year is 2004
